Tuis2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Vorige sluiting
$13,76
Dagwisseling
$13,84 - $14,04
Jaarwisseling
$11,52 - $19,50
Markkapitalisasie
61,33 mjd HKD
Gemiddelde volume
5,41 m
P/V-verhouding
12,63
Dividend-opbrengs
-
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 9,42 mjd | -7,26% |
Bedryfskoste | 3,85 mjd | -6,02% |
Netto inkomste | 764,76 m | 25,42% |
Netto winsgrens | 8,12 | 35,33% |
Wins per aandeel | — | — |
EBITDA | 1,28 mjd | -22,50% |
Effektiewe belastingkoers | 30,13% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 16,07 mjd | 6,98% |
Totale bates | 117,99 mjd | 3,73% |
Totale aanspreeklikheid | 57,14 mjd | 1,66% |
Totale ekwiteit | 60,85 mjd | — |
Uitstaande aandele | 2,64 mjd | — |
Prys om te bespreek | 0,76 | — |
Opbrengs op bates | 1,37% | — |
Opbrengs op kapitaal | 1,68% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 764,76 m | 25,42% |
Kontant van bedrywe | 1,06 mjd | 15,08% |
Kontant van beleggings | -185,09 m | 84,46% |
Kontant van finansiering | -633,63 m | -742,38% |
Netto kontantverandering | 245,87 m | 262,03% |
Beskikbare kontantvloei | -1,89 mjd | -2,13% |
Meer oor
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Gestig
1994
Webwerf
Werknemers
40 557
